{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:16Z","timestamp":1786985596858,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.cancergencyto.2010.09.006","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T04:26:06Z","timestamp":1287116766000},"page":"30-36","source":"Crossref","is-referenced-by-count":52,"title":["Solid tumors associated with multiple endocrine neoplasias"],"prefix":"10.1016","volume":"203","author":[{"given":"Madson Q.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.09.006_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.pas.0000147402.95391.41","article-title":"Familial multiple endocrine neoplasia: the first 100 years","volume":"29","author":"Carney","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/jcem-13-1-20","article-title":"Multiple endocrine adenomas; report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved","volume":"13","author":"Underdahl","year":"1953","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005792-196809000-00001","article-title":"Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing\u2019s disease: multiple endocrine neoplasia, type 2","volume":"47","author":"Steiner","year":"1968","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0300-595X(80)80035-1","article-title":"Multiple endocrine neoplasia type 2","volume":"9","author":"Sizemore","year":"1980","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1677\/erc.1.00683","article-title":"Von Hippel\u2013Lindau disease and endocrine tumour susceptibility","volume":"13","author":"Woodward","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib6","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1210\/jc.2006-2833","article-title":"Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1","volume":"92","author":"Bausch","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0002-9343(53)90043-6","article-title":"Pheochromocytoma; its relationship to the neurocutaneous syndromes","volume":"14","author":"Glushien","year":"1953","journal-title":"Am J Med"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib8","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1056\/NEJMc066006","article-title":"Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma","volume":"354","author":"Bausch","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib9","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198112313052704","article-title":"Von Recklinghausen neurofibromatosis","volume":"305","author":"Riccardi","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel\u2013Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib12","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMc071191","article-title":"Familial gastrointestinal stromal tumors and germ-line mutations","volume":"357","author":"McWhinney","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib16","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jc.2009-1156","article-title":"Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors","volume":"94","author":"Carney","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1085-5629(05)80003-3","article-title":"Carney complex: the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas","volume":"14","author":"Carney","year":"1995","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CCO.0b013e32801195eb","article-title":"Carney complex: the first 20 years","volume":"19","author":"Boikos","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0190-9622(84)80047-X","article-title":"Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: the \u201cLAMB\u201d syndrome","volume":"10","author":"Rhodes","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.1980.tb07266.x","article-title":"A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome","volume":"103","author":"Atherton","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib22","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","article-title":"Guidelines for diagnosis and therapy of MEN type\u00a01 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/edrv-8-4-391","article-title":"Familial multiple endocrine neoplasia type I: a new look at pathophysiology","volume":"8","author":"Brandi","year":"1987","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/GIM.0b013e3181be5c97","article-title":"Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors","volume":"11","author":"Falchetti","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1572-0241.2006.00367.x","article-title":"Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type\u00a01","volume":"101","author":"Thomas-Marques","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2265.1997.3311122.x","article-title":"Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types","volume":"47","author":"Corbetta","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005792-199701000-00002","article-title":"Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1","volume":"76","author":"Teh","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib29","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1586\/14737140.8.4.625","article-title":"RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer","volume":"8","author":"Lodish","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib31","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1158\/1078-0432.CCR-08-2742","article-title":"Targeting the RET pathway in thyroid cancer","volume":"15","author":"Wells","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib32","first-page":"2039","article-title":"Characterization of RET proto-oncogene 3\u2032 splicing variants and polyadenylation sites: a novel C-terminus for RET","volume":"11","author":"Myers","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib33","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1007\/s00018-004-4276-8","article-title":"Dysfunction of the RET receptor in human cancer","volume":"61","author":"Santoro","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib34","first-page":"481","article-title":"Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation","volume":"12","author":"Iwashita","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1359-6101(01)00012-0","article-title":"The GDNF\/RET signaling pathway and human diseases","volume":"12","author":"Takahashi","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib36","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.suc.2009.06.021","article-title":"Sporadic and familial medullary thyroid carcinoma: state of the art","volume":"89","author":"Moo-Young","year":"2009","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1995.tb01903.x","article-title":"Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma","volume":"43","author":"Eng","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.beem.2009.08.001","article-title":"Tyrosine kinase inhibitors and the thyroid","volume":"23","author":"Sherman","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib41","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib42","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1158\/1078-0432.CCR-09-1237","article-title":"Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients","volume":"15","author":"Erlic","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2174\/1566524043359827","article-title":"Von Hippel\u2013Lindau disease","volume":"4","author":"Maher","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00005392-199909010-00004","article-title":"Clinical and genetic characterization of pheochromocytoma in von Hippel\u2013Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma","volume":"162","author":"Walther","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib45","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1158\/0008-5472.CAN-07-0391","article-title":"Von Hippel\u2013Lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development","volume":"67","author":"Kuehn","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gde.2006.12.006","article-title":"Hypoxia-inducible factors: central regulators of the tumor phenotype","volume":"17","author":"Gordan","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib47","doi-asserted-by":"crossref","unstructured":"Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med;12:1\u201311.","DOI":"10.1097\/GIM.0b013e3181bf15e3"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib48","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1158\/0008-5472.CAN-08-4057","article-title":"Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out","volume":"69","author":"Neumann","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/jmg.2007.051045","article-title":"Genetic screening for pheochromocytoma: should SDHC gene analysis be included?","volume":"44","author":"Mannelli","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ncpendmet0726","article-title":"Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation","volume":"4","author":"Peczkowska","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib51","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing","volume":"91","author":"Brouwers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib52","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaad.2008.07.032","article-title":"Heterogeneity of skin manifestations in patients with Carney complex","volume":"59","author":"Mateus","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1755-148X.2009.00613.x","article-title":"Carney complex and lentiginosis","volume":"22","author":"Horvath","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib54","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2032-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib55","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jc.86.9.4041","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib56","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1210\/jc.2004-0055","article-title":"Hypodense nodularity on computed tomography: novel imaging and pathology of micronodular adrenocortical hyperplasia associated with myelolipomatous changes","volume":"89","author":"Courcoutsakis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib57","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1210\/jc.85.10.3860","article-title":"Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the \u201ccomplex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas\u201d (Carney complex)","volume":"85","author":"Pack","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1515\/JPEM.2000.13.4.374","article-title":"Prolactin secretion abnormalities in patients with the \u201csyndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas\u201d (Carney complex)","volume":"13","author":"Raff","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib60","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/hmg\/9.20.3037","article-title":"Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex","volume":"9","author":"Kirschner","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib61","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng1809","article-title":"A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia","volume":"38","author":"Horvath","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib62","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJMc0706182","article-title":"Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia","volume":"358","author":"Horvath","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.09.006_bib63","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1210\/jc.2007-0797","article-title":"Genetics of Carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors","volume":"92","author":"Matyakhina","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810004966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810004966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T10:19:08Z","timestamp":1559729948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810004966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0165460810004966"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.09.006","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}